Trials / Terminated
TerminatedNCT00369499
STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 656 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this Study is to compare the effect of transcatheter device closure of atrial shunting to a non-closure control group over a period from cessation of procedure related medication at 3 months until 9 months post randomization by determining the proportion of patients that experience a 50% or more reduction in the baseline monthly migraine attack frequency in each group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PFO Closure |
Timeline
- Start date
- 2007-03-01
- Completion
- 2009-06-01
- First posted
- 2006-08-29
- Last updated
- 2023-06-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00369499. Inclusion in this directory is not an endorsement.